Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 24.47 Billion INR | -36.23% |
| 2022 | 38.37 Billion INR | 5.12% |
| 2021 | 36.5 Billion INR | 119.84% |
| 2020 | 16.6 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 14.45 Billion INR | 35.32% |
| 2024 Q1 | 5.12 Billion INR | -39.54% |
| 2023 Q1 | 11.22 Billion INR | 43.32% |
| 2023 FY | 24.47 Billion INR | -36.23% |
| 2023 Q4 | 8.47 Billion INR | -33.95% |
| 2023 Q3 | 12.83 Billion INR | 0.77% |
| 2023 Q2 | 12.73 Billion INR | 13.5% |
| 2022 Q2 | 10.56 Billion INR | 16.35% |
| 2022 Q1 | 9.07 Billion INR | 171.45% |
| 2022 FY | 38.37 Billion INR | 5.12% |
| 2022 Q4 | 7.82 Billion INR | -28.21% |
| 2022 Q3 | 10.9 Billion INR | 3.28% |
| 2021 Q2 | 9.71 Billion INR | 0.0% |
| 2021 FY | 36.5 Billion INR | 119.84% |
| 2021 Q4 | -12.7 Billion INR | -228.09% |
| 2021 Q3 | 9.91 Billion INR | 2.08% |
| 2020 FY | 16.6 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 8.625% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 84.18% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -96.822% |
| Granules India Limited | 16.79 Billion INR | -45.666% |
| Indoco Remedies Limited | 6.04 Billion INR | -305.059% |
| Achyut Healthcare Limited | 4.86 Million INR | -503312.878% |
| Ajanta Pharma Limited | 21.06 Billion INR | -16.174% |
| Alkem Laboratories Limited | 52.29 Billion INR | 53.208% |
| Alpa Laboratories Limited | 188.89 Million INR | -12854.763% |
| Brooks Laboratories Limited | 65.62 Million INR | -37191.832% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -293.252% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1562.644% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -562.193% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 85.043% |
| Eris Lifesciences Limited | 10.42 Billion INR | -134.693% |
| FDC Limited | 8.33 Billion INR | -193.601% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 64.709% |
| Gufic Biosciences Limited | 4.16 Billion INR | -487.155% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -295.051% |
| Ipca Laboratories Limited | 29.8 Billion INR | 17.91% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -3649.812% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -12597.183% |
| Lasa Supergenerics Limited | 121.02 Million INR | -20118.872% |
| Laurus Labs Limited | 24.62 Billion INR | 0.606% |
| Lupin Limited | 123.71 Billion INR | 80.22% |
| Mankind Pharma Limited | 44.52 Billion INR | 45.035% |
| Medicamen Biotech Limited | 495.49 Million INR | -4838.677% |
| Medico Remedies Limited | 262.14 Million INR | -9234.908% |
| Megasoft Limited | 342.07 Million INR | -7053.749% |
| NATCO Pharma Limited | 25.73 Billion INR | 4.916% |
| RPG Life Sciences Limited | 2.48 Billion INR | -885.538% |
| Sigachi Industries Limited | 2 Billion INR | -1122.15% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 90.533% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -493.482% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2496.66% |
| Unichem Laboratories Limited | 4.86 Billion INR | -403.006% |
| Wanbury Limited | 1.73 Billion INR | -1313.977% |
| Windlas Biotech Limited | 1.33 Billion INR | -1727.823% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1831.577% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 80.456% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 4162.194% |
| Divi's Laboratories Limited | 32.44 Billion INR | 24.566% |
| Hester Biosciences Limited | 1.27 Billion INR | -1821.321% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -323.269% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -1472.142% |
| Bal Pharma Limited | 770.19 Million INR | -3077.234% |
| Strides Pharma Science Limited | 14.38 Billion INR | -70.077% |
| Venus Remedies Limited | 2.18 Billion INR | -1021.189% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -319.644% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -723.365% |
| Shilpa Medicare Limited | 3.54 Billion INR | -589.931% |
| Aarti Drugs Limited | 8.31 Billion INR | -194.256% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -434.206% |
| Suven Life Sciences Limited | -200.79 Million INR | 12286.885% |
| Ind-Swift Limited | 2.17 Billion INR | -1026.377% |
| Valiant Laboratories Limited | -60.66 Million INR | 40438.421% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -7.802% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -2741.489% |
| Themis Medicare Limited | 1.5 Billion INR | -1527.158% |
| Hikal Limited | 3.14 Billion INR | -678.564% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 47.664% |
| Sequent Scientific Limited | 2.97 Billion INR | -721.521% |
| Novartis India Limited | 1.32 Billion INR | -1744.216% |
| Wockhardt Limited | 16.24 Billion INR | -50.683% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -24.578% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -167742.274% |
| Neuland Laboratories Limited | 8.24 Billion INR | -196.695% |
| Morepen Laboratories Limited | 6.16 Billion INR | -297.172% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -3843.885% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -3377.932% |